Impact and optimal timing of local therapy addition in borderline resectable or locally advanced pancreatic cancer after FOLFIRINOX chemotherapy

Background: To evaluate the efficacy and optimal timing of local treatment in patients with borderline resectable (BR) or locally advanced pancreatic cancer (LAPC) treated with upfront FOLFIRINOX. Method: Between 2015 and 2020, 258 patients with pancreatic ductal adenocarcinoma (PDAC) were analysed....

Mô tả đầy đủ

Chi tiết về thư mục
Những tác giả chính: Kangpyo Kim, Hee Chul Park, Jeong Il Yu, Joon Oh Park, Jung Yong Hong, Kyu Taek Lee, Kwang Hyuck Lee, Jong Kyun Lee, Joo Kyung Park, Jin Seok Heo, Sang Hyun Shin, Ji Hye Min, Kyunga Kim, In Woong Han
Định dạng: Bài viết
Ngôn ngữ:English
Được phát hành: Elsevier 2024-03-01
Loạt:Clinical and Translational Radiation Oncology
Những chủ đề:
Truy cập trực tuyến:http://www.sciencedirect.com/science/article/pii/S2405630824000090